The Vanguard Group 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD |
The Vanguard Group | 28,492,486 9.720% |
1,954,115 (+7.36%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD |
The Vanguard Group | 26,538,371 9.450% |
893,187 (+3.48%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
The Vanguard Group | 25,645,184 9.200% |
1,799,751 (+7.55%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
The Vanguard Group | 23,845,433 9.150% |
86,273 (+0.36%) |
Filing |